Histology and Immunophenotype of Invasive Lobular Breast Cancer. Daily Practice and Pitfalls by Varga, Z & Mallon, E
University of Zurich
Zurich Open Repository and Archive
Winterthurerstr. 190
CH-8057 Zurich
http://www.zora.uzh.ch
Year: 2009
Histology and Immunophenotype of Invasive Lobular Breast
Cancer. Daily Practice and Pitfalls
Varga, Z; Mallon, E
Varga, Z; Mallon, E (2009). Histology and Immunophenotype of Invasive Lobular Breast Cancer. Daily Practice
and Pitfalls. Breast Disease, 30:15-19.
Postprint available at:
http://www.zora.uzh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.uzh.ch
Originally published at:
Breast Disease 2009, 30:15-19.
Varga, Z; Mallon, E (2009). Histology and Immunophenotype of Invasive Lobular Breast Cancer. Daily Practice
and Pitfalls. Breast Disease, 30:15-19.
Postprint available at:
http://www.zora.uzh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.uzh.ch
Originally published at:
Breast Disease 2009, 30:15-19.
Histology and Immunophenotype of Invasive Lobular Breast
Cancer. Daily Practice and Pitfalls
Abstract
Invasive lobular carcinomas (ILC) represent the most common subtype of invasive breast cancer and
account for about 5-15% of all breast cancer cases. Invasive lobular carcinoma is often accompanied by
in situ lesions, by lobular neoplasia (LN). Invasive lobular carcinomas display diverse histologic
patterns varying from classical through solid to pleomorphic subtypes. When analyzing histological
subtypes, the classical variant is reported to have a more favorable outcome. The majority of invasive
lobular carcinomas are hormone receptor positive, overexpression and/or amplification of the Her2 gene
is lower than in carcinomas of invasive ductal type. Loss of heterozygosity of the 16q chromosomal
regions and the consequent lack of E-Cadherin expression are common findings in invasive lobular
carcinomas. Intra-operative evaluation of resection margins in ILC is often unsatisfactory due to the
diffuse nature of the tumor. Size estimation of the invasive component poses a similar challenge in daily
practice.
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Abstract. Invasive lobular carcinomas (ILC) represent the most common subtype of invasive breast cancer and account for about
5–15% of all breast cancer cases. Invasive lobular carcinoma is often accompanied by in situ lesions, by lobular neoplasia (LN).
Invasive lobular carcinomas display diverse histologic patterns varying from classical through solid to pleomorphic subtypes.
When analyzing histological subtypes, the classical variant is reported to have a more favorable outcome. The majority of
invasive lobular carcinomas are hormone receptor positive, overexpression and/or amplification of the Her2 gene is lower than
in carcinomas of invasive ductal type. Loss of heterozygosity of the 16q chromosomal regions and the consequent lack of
E-Cadherin expression are common findings in invasive lobular carcinomas. Intra-operative evaluation of resection margins in
ILC is often unsatisfactory due to the diffuse nature of the tumor. Size estimation of the invasive component poses a similar
challenge in daily practice.
GROSS PATHOLOGY
Invasive lobular carcinomas present mostly as an ir-
regular, infiltrating, poorly delineated mass rather than
a sharply demarcated lesion. Invasive lobular carcino-
mas often display multifocality in the ipsilateral breast
and have a higher tendency to develop bilaterality than
other tumor types. The size of the invasive component
varies considerably (from millimeters to several cen-
timeters). The edges of the tumor mass are often diffi-
cult to evaluate and may be best appreciated by palpa-
tion. The cut surface often appears as an inconspicu-
ous, grey or white area. In other cases there is no gross-
ly visible mass and the tumor can only be appreciated
by palpation or not at all [1–4].
GENERAL HISTOLOGICAL ASPECTS
The original definition of invasive lobular carcinoma
comes from Stewart and Foote, who described the clas-
∗Corresponding author. E-mail: varga@usz.ch.
sical infiltrative subtype [1–4]. Invasive lobular carci-
nomas display characteristic cytologic features and a
distinct infiltration pattern of the stroma. Classical in-
vasive lobular carcinomas are composed of single cells,
infiltrating in strands. In some cases focal tubule for-
mation is seen. The classic pattern of invasive lobular
carcinomas are characterized by a small uniform cell
population, lacking cohesion and invading the stroma
as individual tumor cells, resulting in a ‘single-file’ or
‘Indian-file’ pattern of growth. Sometimes tumor cells
are located around benign ducts in a circular fashion
resulting in a targetoid appearance. Tumor cells usu-
ally have a round nucleus, thin cytoplasm with occa-
sional cytoplasmic vacuoles. The nuclei are usually
small, eccentric and show little variation in size, nu-
cleoli are absent or inconspicuous. Mitotic figures are
rare. The classical form of invasive lobular carcino-
ma is often accompanied by in situ lesions of lobular
neoplasia occurring in 40–60% of invasive carcinomas.
Invasive lobular carcinoma is sometimes accompanied
by a prominent lymphocytic or granulomatous reac-
tion. The histological diagnosis of classical lobular
0888-6008/09/$17.00 © 2009 – IOS Press and the authors. All rights reserved
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Fig. 1. Special types of invasive lobular breast cancer. A) classical type (HE). B) histiocytoid variant (HE). C) pleomorphic variant (HE). D)
alveolar variant (HE). Magnification: 300X.
carcinomas requires at least 70% of single-file growth
pattern [1–4].
SPECIAL SUBTYPES OF INVASIVE LOBULAR
CARCINOMA (see Figs 1 and 2)
Several histological variants of invasive lobular car-
cinoma have been described.
Solid pattern: this pattern is characterized by sheets
of uniform cells, lacking cohesion, resulting in a growth
pattern in large confluent areas with little or absent
stroma in between.
Alveolar pattern: in this variation tumor cells are
arranged in small clusters or nests of approximately 20
cells, separated by delicate fibrovascular septa.
Trabecular pattern: this variant represents a histo-
logical overlap between classical and so called trabec-
ular filing pattern. This morphological coincidence is
due to the morphological similarity between ‘single
file’ seen in the classical variant and ‘one-cell-thick-
trabecules’ observed in the trabecular variant.
Tubulolobular pattern: this lesion is composed of
small tubular structures as well of single cell files seen
in classical lobular carcinomas. This category repre-
sents a morphological overlap between invasive tubular
and invasive classical lobular carcinoma, traditionally
categorized as a variant of invasive lobular carcinoma.
Pleomorphic variant: this variant represents a dis-
tinct subtype of invasive lobular carcinoma with similar
growth pattern and stroma infiltration as seen in oth-
er subtypes. However, the tumor cells are larger and
exhibit more cellular atypia and pleomorphism. The
cytoplasm is more abundant and it often shows some
eosinophilia. Recurrence free survival is reportedly
poorer in pleomoprhic lobular carcinomas than in clas-
sical lobular carcinomas. Pleomorphic lobular carci-
nomas can display apocrine, signet ring cell and histi-
cytoid differentiation. Apocrine differentiation in in-
vasive lobular carcinomas has been found to have an
especially aggressive clinical course.
Histiocytoid variant: in this variant tumor cells have
a pale appearance with foamy cytoplasm and mild nu-
clear variation.
Signet cell variant: this subtype occurs in invasive
breast carcinomas with a growth pattern of a lobular
carcinoma, consisting of a prominent component of
signet ring cells.
Mixed lobular carcinomas: this group shows an ad-
mixture of classical lobular carcinoma accompanied by
at least one more additional pattern, which could be
either a special type of invasive lobular carcinoma or
of invasive ductal carcinoma [1–4].
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Fig. 2. Special types of invasive lobular breast cancer. A) intracellular mucin production (HE). B) intracellular mucin production (Alcian blue
PAS). C) Mixed carcinoma, ductal (left) and lobular (right) (HE). D) Negative immunoreactivity for E-Cadherin (E-Cadherin). Magnification:
300X (A,B,D) 50X (C).
GRADING OF INVASIVE LOBULAR
CARCINOMA
Grading of invasive lobular carcinomas is widely
accepted in routine surgical pathology despite the fact,
that the application of BRE Score is somewhat special
in this tumor type. There is no tubular formation in
invasive lobular carcinomas, therefore, a score of 3 has
to be attributed for tubule formation. Mitotic activity is
usually low (score 1 or 2), nuclear pleomorphism can
vary from monotonous to largely pleomorphic nuclei
(score 1 to 3). Therefore, the majority of invasive
lobular carcinomas are classified as grade 2, due to
moderate nuclear pleomorphism and low mitotic rate.
Classical lobular carcinomas can be graded as grade 1,
if tumor cells exhibit round small monotonous nuclei.
Pleomorphic lobular carcinomas can be also graded as
grade 3 if sufficient mitotic figures are present [3,5–7].
DIFFERENTIAL DIAGNOSIS
Lymphatic proliferation
Invasive lobular carcinomas can closely resemble an
atypical lymphatic proliferation. This diagnostic chal-
lenge preferentially occurs with suboptimal tissue fix-
ation. The use of immunohistochemistry (cytokeratin
in the neoplastic cells) or the detection of cytoplas-
mic vacuoles containing mucin, should easily identi-
fy the lesion as invasive lobular carcinoma. Rarely,
inflammatory cells can mimic invasive lobular cancer
cells, which can be challenging particularly on frozen
sections. The evidence of in situ components, lobular
neoplasia, may be helpful in such settings [1,2,4,5].
Invasive ductal carcinoma
The distinction between lobular and ductal carcino-
mas can pose a diagnostic difficulty based on histol-
ogy alone. Invasive ductal carcinomas can display a
growth pattern similar to invasive lobular carcinomas
since tumor cells spreading in single files can occur in
invasive ductal carcinomas. The evidence of peri- or
intratumoral lobular neoplasia (LN) or ductal carcino-
ma in situ (DCIS) may be of some help, however this
is of limited value as in situ components can be present
independently of the histology of the invasive compo-
nent. Intracytoplasmic vacuoles and areas of single
cell infiltration favor the diagnosis of invasive lobular
carcinoma. Immunostains for E-Cadherin, hormone
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receptors, gross-cystic disease fluid protein, p120 can
support the correct diagnosis. Generally, the absence
of E-Cadherin expression on the cell membrane and in
most cases strong hormone receptor expression favor
the diagnosis of invasive lobular carcinoma (see also
paragraph below) [2,8–13].
Fat necrosis
The histiocytoid variant of invasive lobular carcino-
ma may be particularly difficult to differentiate from fat
necrosis in some instances, as tumor cells can mimic re-
active histiocytic infiltration and vica versa. Immuno-
histochemistry for macrophage markers (e.g. CD68)
and cytokeratins should lead to the correct diagnosis [4,
5].
IMMUNOHISTOCHEMISTRY
Hormone receptors
The large majority of invasive lobular carcinomas
show strong expression of estrogen and progesterone
receptors, a higher rate than in invasive ductal carcino-
mas [2–4].
Her2 gene and protein
Her2 protein expression and/or gene amplification
are rare events in invasive lobular carcinomas. The
pleomorphic variant of invasive lobular carcinomas rep-
resents an exception to this rule, as Her2 gene ampli-
fication and protein expression, particularly in grade 3
cases have been described in the literature [2,14].
Proliferation index (MIB-1)
Proliferation index is generally low in invasive lob-
ular carcinomas. In some studies distinct differences
in proliferation activity were detected in classical ver-
sus pleomorphic subtypes varying from 2.9% (classical
type) to 8–11% (pleomorphic variants). The prolifer-
ation fraction of invasive ductal carcinomas is usually
higher, in grade 3 cases the MIB-1 labeling index often
reaches 25–30% or even higher [15].
E-Cadherin
The transmembrane protein E-Cadherin which me-
diates cell-cell adhesion and acts as an invasion sup-
pressor factor, had been reported to be a reliable marker
in the differentiation of ductal and lobular breast car-
cinomas. Ductal carcinomas usually express membra-
nous E-Cadherin reactivity, while invasive lobular car-
cinomas are mostly negative. Therefore, the absence of
E-Cadherin positivity is a significant finding in the di-
agnosis of invasive lobular carcinomas. Together with
conventional histology, a negative E-Cadherin reaction
is the most helpful immunhistochemical marker. Con-
versely, in a subset of poorly differentiated invasive
ductal carcinomas (less than 15%), E-Cadherin may
be absent. In these cases other morphological features
such as tubule formation, hormone receptor status and
additional immunohistochemistry are needed to con-
firm the diagnosis of an E-Cadherin negative invasive
ductal carcinoma [8,12,13,16,17].
P120
The interaction of E-Cadherin with catenins such as
p120 has been documented in previous studies. Cyto-
plasmic positivity for p120 generally favors the diagno-
sis of lobular carcinoma, as membranous reaction has
mostly been reported in invasive ductal carcinoma [10,
17].
GCDPF-15 (gross cystic disease fluid protein)
Approximately one third of the invasive lobular car-
cinomas are positive for GCDFP-15, a marker for apoc-
rine differentiation. Invasive lobular carcinomas with
histiocytoid, pleomorphic or signet ring cell compo-
nents tend to express GCDFP-15. Positivity for this
marker however does not necessarily confirms the di-
agnosis of invasive lobular carcinoma, as GCDFP-15
can be seen in other breast cancer subtypes such as
apocrine, endocrine, oncocytic and acinic cell carcino-
mas and some positivity has been reported in invasive
ductal carcinomas as well [2–4].
Cytokeratin 5/6
Invasive lobular carcinomas are reportedly negative
for cytokeratin 5/6. In recent studies a subset (15%) of
invasive lobular carcinomas tested positive for cytoker-
atin 5/6, which also were preferentially hormone recep-
tor negative, leading to postulating a distinct basal like
ILC subtype. However, no definite morphological dif-
ferences could be found upon cytokeratin 5/6 positivity
among invasive lobular carcinomas [11,16,17].
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Cyclin D
Cyclin D1 can evoke hormone receptor activation
through binding to estrogen receptors. Overexpression
of Cyclin D1 has been reported in over 80% of invasive
lobular carcinomas. However, this positivity is not
specific for a definitive lobular differentiation, as it can
occur in other subtypes as well [3,4].
PROGNOSIS
In general, prognosis of invasive lobular carcinomas
does not consistently differ from invasive ductal car-
cinomas. However when histological subtypes of ILC
are analyzed one by one, a more favorable outcome has
been reported for the classical type of invasive lobular
carcinoma. In some studies, the pleomorphic and the
signet ring cell variants have been associated with poor-
er outcome. Also, the metastatic pattern of invasive
lobular carcinomas differs from invasive ductal breast
carcinomas. Higher rates of bone, gastro-intestinal
tract, meningeal and/or ovarian metastases have been
documented in invasive lobular carcinomas [3,18,19].
PITFALLS IN ROUTINE PRAXIS
Frozen sections
Differentiation of invasive lobular carcinoma cells
from inflammatory cells,fibroblasts or cells from hema-
tological malignancies can be very difficult on frozen
sections. Searching for other features such as lobu-
lar neoplasia, characteristic growth pattern, stromal in-
filtration or overtly malignant epithelial cells may be
helpful. If available, cytokeratin immunohistocemistry
adapted for frozen sections, can be applied as well.
The intra-operative assessment of involvement of
surgical margins by invasive lobular carcinoma is often
unsatisfactory as no palpable tumor mass is present at
gross examination for the correct selection of suspi-
cious edges.
References
[1] P. Rosen, Rosen’s Breast Pathology, First ed., Lippincott-
Raven, 1997.
[2] S.J. Schnitt and L.C. Collins, Biopsy Interpretation of the
Breast, Biopsy Interpretation Series, 1009: Wolters Kluwer
Health.
[3] F.A. Tavassoli and P. Devilee, Tumours of the Breast and
Female Genital Organs, IARC Press, Lyon, 2003.
[4] F. Tavassoli, Pathology of the Breast, Appleton & Langem
Stanford Connecticut, 1999.
[5] E. Provenzano and S.E. Pinder, Pre-operative diagnosis of
breast cancer in screening: problems and pitfalls, Pathology
41(1) (2009), 3–17.
[6] E.A. Rakha et al., Histologic grading is an independent prog-
nostic factor in invasive lobular carcinoma of the breast, Breast
Cancer Res Treat 111(1) (2008), 121–127.
[7] M.L. Talman, M.B. Jensen and F. Rank, Invasive lobular
breast cancer. Prognostic significance of histological malig-
nancy grading, Acta Oncol 46(6) (2007), 803–809.
[8] G. Acs et al., Differential expression of E-cadherin in lobular
and ductal neoplasms of the breast and its biologic and diag-
nostic implications, Am J Clin Pathol 115(1) (2001), 85–98.
[9] L. Da Silva et al., Aberrant expression of E-cadherin in lobular
carcinomas of the breast, Am J Surg Pathol 32(5) (2008), 773–
783.
[10] D.J. Dabbs, R. Bhargava and M. Chivukula, Lobular versus
ductal breast neoplasms: the diagnostic utility of p120 catenin,
Am J Surg Pathol 31(3) (2007), 427–437.
[11] O. Fadare, S.A. Wang and D. Hileeto, The expression of cytok-
eratin 5/6 in invasive lobular carcinoma of the breast: evidence
of a basal-like subset? Hum Pathol 39(3) (2008), 331–336.
[12] I.T. Yeh and C. Mies, Application of immunohistochemistry to
breast lesions, Arch Pathol Lab Med 132(3) (2008), 349–358.
[13] B.J. Yoder, E.J. Wilkinson and N.A. Massoll, Molecular and
morphologic distinctions between infiltrating ductal and lob-
ular carcinoma of the breast, Breast J 13(2) (2007), 172–179.
[14] Z. Varga et al., Preferential HER-2/neu overexpression and/or
amplification in aggressive histological subtypes of invasive
breast cancer, Histopathology 44(4) (2004), 332–338.
[15] D. Frolik, R. Caduff and Z. Varga, Pleomorphic lobular carci-
noma of the breast: its cell kinetics, expression of oncogenes
and tumour suppressor genes compared with invasive duc-
tal carcinomas and classical infiltrating lobular carcinomas,
Histopathology 39(5) (2001), 503–513.
[16] R. Mahler-Araujo et al., Reduction of E-cadherin expression
is associated with non-lobular breast carcinomas of basal-like
and triple negative phenotype, J Clin Pathol 61(5) (2008),
615–620.
[17] T. Moriya et al., The role of immunohistochemistry in the dif-
ferential diagnosis of breast lesions, Pathology 41(1) (2009),
68–76.
[18] B.C. Pestalozzi et al., Distinct clinical and prognostic features
of infiltrating lobular carcinoma of the breast: combined re-
sults of 15 International Breast Cancer Study Group clinical
trials, J Clin Oncol 26(18) (2008), 3006–3014.
[19] X. Sastre-Garau et al., Infiltrating lobular carcinoma of the
breast. Clinicopathologic analysis of 975 cases with reference
to data on conservative therapy and metastatic patterns, Cancer
77(1) (1996), 113–120.
